Mankind Pharma Limited v. Kindmans Laboratories Limited
Case brief
What is this about?
Mankind Pharma v. Kindmans Laboratories; CS(COMM) 1085/2024; Delhi High Court; Saurabh Banerjee, J.; 07.05.2025; trade mark infringement/passing off; consent decree; joint application under Order XXIII Rule 3 CPC; settlement; MANKIND, KIND, KINDMAN and KIND-formative marks; deceptively similar trade name KINDMANS LABORATORIES LIMITED; closure of defendant company within 30 days; withdrawal of trade mark application no. 5375124 Class 35; transfer of domain www.kindmans.com; takedown of listings and social media references; decree in terms of prayer clauses (a) to (e); damages, rendition of accounts and costs not pressed; refund of 75% court fees; Section 16 Court Fees Act 1870; suit disposed of.
What did the court decide?
Suit decreed in terms of the settlement in paragraph 2 of I.A. 11530/2025: defendant acknowledged plaintiff as sole and exclusive proprietor of MANKIND/KIND/KINDMAN and KIND-formative marks; undertook non-use of KINDMAN marks/trade/corporate name, closure of the company within 30 days, withdrawal of trade mark application no. 5375124 (Class 35) within 15 days, transfer of domain www.kindmans.com, and takedown of listings and references within 15 days; plaintiff not pressing damages, rendition of accounts and costs; certificate for refund of 75% of court fees to be issued by the Registry.